Eledon Pharmaceuticals (ELDN) Accumulated Depreciation (2013 - 2016)
Eledon Pharmaceuticals (ELDN) posted Accumulated Depreciation of $130000.0 for Q4 2016, down 21.21% on a QoQ basis from $165000.0 in Q4 2015, and down 21.21% year-over-year from $165000.0 in Q1 2016.
Eledon Pharmaceuticals (ELDN) Accumulated Depreciation (2013 - 2016) Analysis & Trends
Eledon Pharmaceuticals' Accumulated Depreciation history runs 4 years deep, the most recent figure standing at $130000.0 for Q4 2016.
- Quarterly Accumulated Depreciation fell 21.21% year-over-year to $130000.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $130000.0 (down 21.21% YoY) and the FY2016 annual result came in at $130000.0, down 21.21% from the prior year.
- Accumulated Depreciation was $130000.0 for Q4 2016 at Eledon Pharmaceuticals, down from $165000.0 in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $165000.0 in Q4 2015 and bottomed at $43000.0 in Q4 2013.
- A 4-year average of $99000.0 and a median of $94000.0 in 2014 frame the typical range for Accumulated Depreciation.
- Annual changes were most pronounced in 2015 — Accumulated Depreciation soared 184.48% — and 2016, when it dropped 21.21%.
- Eledon Pharmaceuticals' Accumulated Depreciation stood at $43000.0 in 2013, then surged by 34.88% to $58000.0 in 2014, then soared by 184.48% to $165000.0 in 2015, then declined by 21.21% to $130000.0 in 2016.
- Business Quant data shows ELDN's Accumulated Depreciation at $130000.0 in Q4 2016, $165000.0 in Q4 2015, and $58000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,440.76 Bn | 66,440.47 Bn | - |
| 2 | Nanobiotix | 1,880.51 Bn | 1,880.45 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.94 Bn | 463.15 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.63 Bn | 115.38 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.30 Bn | 61.54 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.81 Bn | 62.81 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.59 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 401.92 Mn | 401.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 130,000.00 |
| Dec 31, 2015 | 165,000.00 |
| Dec 31, 2014 | 58,000.00 |
| Dec 31, 2013 | 43,000.00 |